Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
8.84
-0.03 (-0.34%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Myriad Genetics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
Cash & Equivalents | 102.4 | 132.1 | 56.9 | 257.4 | 117 | Upgrade
|
Short-Term Investments | - | 8.8 | 58 | 81.4 | 33.7 | Upgrade
|
Cash & Short-Term Investments | 102.4 | 140.9 | 114.9 | 338.8 | 150.7 | Upgrade
|
Cash Growth | -27.32% | 22.63% | -66.09% | 124.82% | -30.81% | Upgrade
|
Accounts Receivable | 121.2 | 114.3 | 101.6 | 91.3 | 89.5 | Upgrade
|
Receivables | 121.2 | 114.3 | 101.6 | 91.3 | 89.5 | Upgrade
|
Inventory | 27.5 | 22 | 20.1 | 15.3 | 27.1 | Upgrade
|
Prepaid Expenses | 38.3 | 35.2 | 36 | 39.4 | 122.1 | Upgrade
|
Restricted Cash | 8.6 | 1.2 | 2 | - | - | Upgrade
|
Total Current Assets | 298 | 313.6 | 274.6 | 484.8 | 389.4 | Upgrade
|
Property, Plant & Equipment | 172.4 | 180.6 | 187.3 | 125.3 | 100.4 | Upgrade
|
Long-Term Investments | - | - | 54.8 | 59 | 21 | Upgrade
|
Goodwill | 286.3 | 287.4 | 286.8 | 239.2 | 329.2 | Upgrade
|
Other Intangible Assets | 265.8 | 354.1 | 386.8 | 410.8 | 578.8 | Upgrade
|
Other Long-Term Assets | 5.1 | 10.8 | 8.4 | 1.6 | - | Upgrade
|
Total Assets | 1,028 | 1,147 | 1,199 | 1,321 | 1,419 | Upgrade
|
Accounts Payable | 32.3 | 25.8 | 28.8 | 29.6 | 20.5 | Upgrade
|
Accrued Expenses | 79.9 | 75.7 | 70.2 | 82.7 | 62.1 | Upgrade
|
Current Portion of Leases | 12.8 | 16.2 | 14.1 | 13 | 13.6 | Upgrade
|
Current Income Taxes Payable | 5.1 | 4.6 | 4.8 | 4 | 4.3 | Upgrade
|
Current Unearned Revenue | - | - | - | - | 32.7 | Upgrade
|
Other Current Liabilities | 34 | 33.6 | 19.3 | 75 | 12.7 | Upgrade
|
Total Current Liabilities | 164.1 | 155.9 | 137.2 | 204.3 | 145.9 | Upgrade
|
Long-Term Debt | 39.6 | 38.5 | - | - | 224.8 | Upgrade
|
Long-Term Leases | 87.9 | 97.4 | 130.9 | 79.3 | 50.6 | Upgrade
|
Long-Term Deferred Tax Liabilities | - | - | - | 35.8 | 71.3 | Upgrade
|
Other Long-Term Liabilities | 34.9 | 71.5 | 44.8 | 33.5 | 45.2 | Upgrade
|
Total Liabilities | 326.5 | 363.3 | 312.9 | 352.9 | 537.8 | Upgrade
|
Common Stock | 0.9 | 0.9 | 0.8 | 0.8 | 0.8 | Upgrade
|
Additional Paid-In Capital | 1,458 | 1,416 | 1,260 | 1,226 | 1,110 | Upgrade
|
Retained Earnings | -756.8 | -629.5 | -366.2 | -254.2 | -227 | Upgrade
|
Comprehensive Income & Other | -0.8 | -3.7 | -8.9 | -5.1 | -2.3 | Upgrade
|
Total Common Equity | 701.1 | 783.2 | 885.8 | 967.8 | 881 | Upgrade
|
Shareholders' Equity | 701.1 | 783.2 | 885.8 | 967.8 | 881 | Upgrade
|
Total Liabilities & Equity | 1,028 | 1,147 | 1,199 | 1,321 | 1,419 | Upgrade
|
Total Debt | 140.3 | 152.1 | 145 | 92.3 | 289 | Upgrade
|
Net Cash (Debt) | -37.9 | -11.2 | 24.7 | 305.5 | -117.3 | Upgrade
|
Net Cash Growth | - | - | -91.92% | - | - | Upgrade
|
Net Cash Per Share | -0.42 | -0.14 | 0.31 | 3.92 | -1.57 | Upgrade
|
Filing Date Shares Outstanding | 91.31 | 89.87 | 81.22 | 80.02 | 76.3 | Upgrade
|
Total Common Shares Outstanding | 91.3 | 89.9 | 81.2 | 80 | 75.4 | Upgrade
|
Working Capital | 133.9 | 157.7 | 137.4 | 280.5 | 243.5 | Upgrade
|
Book Value Per Share | 7.68 | 8.71 | 10.91 | 12.10 | 11.68 | Upgrade
|
Tangible Book Value | 149 | 141.7 | 212.2 | 317.8 | -27 | Upgrade
|
Tangible Book Value Per Share | 1.63 | 1.58 | 2.61 | 3.97 | -0.36 | Upgrade
|
Machinery | 148.5 | 147.6 | 124.7 | 112.4 | 117.9 | Upgrade
|
Leasehold Improvements | 78.5 | 91.3 | 67.9 | 38 | 35.7 | Upgrade
|
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.